Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-27T04:46:14.423Z Has data issue: false hasContentIssue false

9 - Routine pediatric care

from Part II - General issues in the care of pediatric HIV patients

Published online by Cambridge University Press:  03 February 2010

By
Elaine Abrams  and
Lisa-Gaye Robinson
Edited by
Steven L. Zeichner  and
Jennifer S. Read
Elaine Abrams
Affiliation:
Associate Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Director, Family Care Center, Associate Attending, Harlem Hospital Center, New York, NY
Lisa-Gaye Robinson
Affiliation:
Assistant Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Assistant Attending, Harlem Hospital Center, New York, NY
Steven L. Zeichner
Affiliation:
National Cancer Institute, Bethesda, Maryland
Jennifer S. Read
Affiliation:
National Cancer Institute, Bethesda, Maryland
Get access

Summary

Introduction

HIV is a chronic illness with diverse clinical manifestations and psychosocial challenges. The routine care of HIV-infected children demands a dedicated multidisciplinary approach from a variety of health care professionals including medical subspecialists, nurses, psychiatrists, psychologists, dentists, social workers, and case managers. The HIV primary care provider, while ensuring health maintenance and preventing disease, must serve as the coordinator of an array of services crucial to the management of these children in the context of the family. There are important management considerations that are essential to the care of both children who are exposed to HIV but determined to be uninfected and children with HIV infection.

Care of the HIV-exposed infant

Routine care for the infant born to an HIV-infected mother should begin well before the infant's birth. Pediatric providers should collaborate with the mother's primary care providers to minimize the risk of HIV transmission. Care of the infant after birth includes continued interventions to reduce the risk of HIV infection, as well as HIV diagnostic evaluations and routine infant care (Table 9.1). Care of the HIV-exposed newborn in the hospital begins with a thorough maternal history, including HIV disease status (HIV RNA concentration (viral load), CD4+ lymphocyte count, and HIV-related complications), receipt of interventions to prevent mother-to-child transmission (e.g. antiretroviral prophylaxis, cesarean section delivery before labor and before ruptured membranes), and history of other infections (e.g. syphilis, herpes simplex virus, hepatitis B and C, cytomegalovirus, toxoplasmosis, gonorrhea, or tuberculosis).

Type
Chapter
Information
Textbook of Pediatric HIV Care , pp. 134 - 144
Publisher: Cambridge University Press
Print publication year: 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Connor, E. M., Sperling, R. S., Gelber, R.. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. New Engl. J. Med. 331: 18 (1994), 1173–80CrossRefGoogle ScholarPubMed
Shaffer, N., Chuachoowong, R., Mock, P. A.. Short-course zidovudine for perinatal Human Immunodeficiency Virus-1 transmission in Bangkok, Thailand: a randomized controlled trial. Lancet 353: 9155 (1999) 773–80CrossRefGoogle Scholar
The PETRA study team. Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of Human Immunodeficiency Virus-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial. Lancet. 359: 9313 (2002), 1178–86CrossRef
Guay, L. A., Musoke, P., Fleming, T.. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of Human Immunodeficiency Virus-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354: 9181 (1999), 795–802CrossRefGoogle ScholarPubMed
Wade, N. A., Birkhead,, G. S., Warren, B. L.. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. New Engl. J. Med. 339: 20 (1998), 1409–14CrossRefGoogle ScholarPubMed
The International Perinatal Human Immunodeficiency Virus Group. The mode of delivery and risk of vertical transmission of Human Immunodeficiency Virus-1- a meta-analysis of 15 prospective cohort studies. N. Engl. J. Med. 340: 13 (1999), 977–87CrossRef
The European mode of delivery collaboration. Elective cesarean-section versus vaginal delivery in prevention of vertical Human Immunodeficiency Virus-1 transmission: a randomized clinical trial. Lancet 353: 9158 (1999), 1035–9CrossRef
Cooper, E. R., Charurat, M., Mofenson, L.. Combination antiretroviral strategies for the treatment of pregnant Human Immunodeficiency Virus-1 infected women and prevention of perinatal Human Immunodeficiency Virus-1 transmission. J Acquired Immune Deficiency Syndrome 29: 5 (2002), 484–94CrossRefGoogle Scholar
Wade, N., Birkhead, G. & French, P. T.Short courses of zidovudine and perinatal transmission of Human Immunodeficiency Virus. New Engl. J. Med. 340 (1999), 1042–3Google Scholar
Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric Human Immunodeficiency Virus infection, 1998. MMWR 47 (No. Relative Risk-4): 1–43 (updates available at http://AIDSInfo.nih.gov)
Hanson, I. C., Antonelli, T. A., Sperling, R. S.. Lack of tumors in infants with perinatal Human Immunodeficiency Virus-1 exposure and fetal/neonatal exposure to zidovudine. J. Acquired Immune Deficiency Syndrome Hum. Retrovirol. 20: 5 (1999), 463–7CrossRefGoogle ScholarPubMed
Blanche, S., Tardieu, M., Rustin, P.. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 354 (1999), 1084–9CrossRefGoogle ScholarPubMed
The Perinatal Safety Review Working Group. Nucleoside exposure in the children of Human Immunodeficiency Virus-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J. Acquired Immune Deficiency Syndrome 25 (2000), 261–8CrossRef
Cunningham, C. K., Charbonneau, T. T., Song, K.. Comparison of human immunodeficiency virus 1 Deoxyribonucleic Acid polymerase chain reaction and qualitative and quantitative Ribonucleic Acid polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr. Infect. Dis. J. 18 (1999), 30–5CrossRefGoogle Scholar
Delamare, C., Burgard, M., Mayaux, M. J.. Human Immunodeficiency Virus-1 Ribonucleic Acid detection in plasma for the diagnosis of infection in neonates. The French Pediatric Human Immunodeficiency Virus Infection Study Group. J. Acquired Immune Deficiency Syndrome Hum. Retrovirol. 15: 2 (1997), 121–5CrossRefGoogle Scholar
Benjamin, D. K., Miller, W. C., Fiscus, S. A.. Rational testing of the Human Immunodeficiency Virus-exposed infant. Pediatrics 108: 1 (2001), E3CrossRefGoogle Scholar
Dunn, D. T., Brandt, C. D., Krivine, A.. The sensitivity of Human Immunodeficiency Virus-1 Deoxyribonucleic Acid polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission. Acquired Immune Deficiency Syndrome9 (1995), F7-11
McKinney, R. E. & Robertson, J. W.Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric Acquired Immune Deficiency Syndrome Clinical Trials Unit. J. Pediatr. 123: 4 (1993), 579–82CrossRefGoogle ScholarPubMed
Abrams, E. J., Matheson, P. B., Thomas, P. A.. Neonatal predictors of infection status and early death among 332 infants at risk of Human Immunodeficiency Virus-1 infection monitored prospectively from birth. Pediatrics 96 (1995), 451–8Google ScholarPubMed
Moye, J., Rich, K. C., Kalish, L. A.. Natural history of somatic growth in infants born to women infected by human immuno-deficiency virus. J. Pediatr. 128 (1996), 58–69CrossRefGoogle Scholar
DeMartino, M., Tovo, P. A., Galli, L.. Puberty in perinatal Human Immunodeficiency Virus-1 infection: a multicenter longitudinal study of 212 children. Acquired Immune Deficiency Syndrome 15: 12 (2001), 1527–34Google Scholar
Arpadi, S. M., Cuff, P. A., Horlick, M., Wang, J. & Kotler, D. P.Lipodystrophy in Human Immunodeficiency Virus-infected children is associated with high viral load and low Cluster of Differentiation4+ -lymphocyte count and Cluster of Differentiation4+ -lymphocyte percentage at baseline and use of protease inhibitors and stavudine. J. Acquired Immune Deficiency Syndrome 27: 1 (2001), 30–4CrossRefGoogle Scholar
Melvin, A. J., Lennon, S., Mohan, K. M. & Purnell, J. Q.Metabolic abnormalities in Human Immunodeficiency Virus type 1-infected children treated and not treated with protease inhibitors. Acquired Immune Deficiency Syndrome Res. Hum. Retroviruses 17: 12 (2001), 1117–23Google Scholar
Centers for Disease Control and Prevention. Recommended Childhood and Adolescent Immunization Schedule-United States, 2004. MMWR, 53 (2004), Q1–3
Diamond, G. W.Developmental problems in children with Human Immunodeficiency Virus infection. Ment. Retard. 27: 4 (1989), 213–7Google Scholar
Brown, L. K., Lourie, K. J. & Pao, M.Children and adolescents living with Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome: a review. J. Child. Psychol. Psychiatry 41: 1 (2000), 81–96CrossRefGoogle ScholarPubMed
Mofenson, L. M., Korelitz, J., Meyer, W. A.. The relationship between serum human immunodeficiency virus type 1 (Human Immunodeficiency Virus-1) Ribonucleic Acid level, Cluster of Differentiation4 lymphocyte percent, and long-term mortality risk in Human Immunodeficiency Virus-1 infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. J. Infect. Dis. 175 (1997), 1029–38CrossRefGoogle Scholar
Abrams, E. J., Weedon, J., Steketee, R. W.. Association of Human Immunodeficiency Virus viral load early in life with disease progression among Human Immunodeficiency Virus-infected infants. J. Infect. Dis. 178 (1998), 101–8CrossRefGoogle Scholar
Shearer, W. T., Quinn, T. C., LaRussa, P.. Viral load and disease progression in infants infected with human immunodeficiency virus type 1. New Engl. J. Med. 336 (1997), 1337–42CrossRefGoogle ScholarPubMed
Palumbo, P. E., Raskino, C., Fiscus, S.. Predictive value of quantitative plasma Human Immunodeficiency Virus Ribonucleic Acid and Cluster of Differentiation4+ lymphocyte count in Human Immunodeficiency Virus-infected infants and children. J. Am. Med. Assoc. 279: 10 (1998), 756–61CrossRefGoogle Scholar
Dunn, D.Human Immunodeficiency Virus Paediatric Prognostic Markers Collaborative Study Group. Short-term risk of disease progression in Human Immunodeficiency Virus-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis. Lancet 362: 9396 (2003): 1605–11Google ScholarPubMed
Centers for Disease Control and Prevention 1999 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. MMWR 48: Relative Risk-10 (1999)
Centers for Disease Control and Prevention 1999 revised guidelines for prophylaxis against Mycobacterium avium intracellulare in patients infected with human immunodeficiency virus. MMWR 48: Relative Risk-10 (1999)
Havens, J. F., Mellins, C. A. & Hunter, J. Psychiatric aspects of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome in childhood and adolescence. In M. Rutter & E. Taylor (eds.), Child and Adolescent Psychiatry: Modern Approaches. Fourth Edition. Oxford, England: Blackwell (2001), pp. 828–41
Mellins, C. A., Brackis-Cott, E., Dolezal, C., Richards, A., Nicholas, S. & Abrams, E. J.Patterns of Human Immunodeficiency Virus status disclosure to perinatally infected Human Immunodeficiency Virus-positive children and subsequent mental health outcomes. Clin. Child Psychol. Psychia 7 (2001), 101–14CrossRefGoogle Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Routine pediatric care
    • By Elaine Abrams, Associate Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Director, Family Care Center, Associate Attending, Harlem Hospital Center, New York, NY, Lisa-Gaye Robinson, Assistant Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Assistant Attending, Harlem Hospital Center, New York, NY
  • Edited by Steven L. Zeichner, National Cancer Institute, Bethesda, Maryland, Jennifer S. Read, National Cancer Institute, Bethesda, Maryland
  • Book: Textbook of Pediatric HIV Care
  • Online publication: 03 February 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544798.012
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Routine pediatric care
    • By Elaine Abrams, Associate Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Director, Family Care Center, Associate Attending, Harlem Hospital Center, New York, NY, Lisa-Gaye Robinson, Assistant Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Assistant Attending, Harlem Hospital Center, New York, NY
  • Edited by Steven L. Zeichner, National Cancer Institute, Bethesda, Maryland, Jennifer S. Read, National Cancer Institute, Bethesda, Maryland
  • Book: Textbook of Pediatric HIV Care
  • Online publication: 03 February 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544798.012
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Routine pediatric care
    • By Elaine Abrams, Associate Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Director, Family Care Center, Associate Attending, Harlem Hospital Center, New York, NY, Lisa-Gaye Robinson, Assistant Professor of Clinical Pediatrics, Columbia University, College of Physicians & Surgeons, Assistant Attending, Harlem Hospital Center, New York, NY
  • Edited by Steven L. Zeichner, National Cancer Institute, Bethesda, Maryland, Jennifer S. Read, National Cancer Institute, Bethesda, Maryland
  • Book: Textbook of Pediatric HIV Care
  • Online publication: 03 February 2010
  • Chapter DOI: https://doi.org/10.1017/CBO9780511544798.012
Available formats
×